Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-80.04	-197.16	987.53
Graham Fair Price	149.45	18.10	7.26
PEG	-98.65	-0.02	1.40
Price/Book	0.36	1.15	1.15
Price/Cash Flow	230.08	8.82	2.67
Prices/Earnings	-84.42	13.98	-89.71
Price/Sales	-14.48	8.22	9.61
Price/FCF	230.08	8.82	2.67
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.59	0.95	1.00
Operating Margin	252.48	0.25	-0.07
ROA	572.26	< 0.005	< 0.005
ROE	< 0.005	0.02	543.97
ROIC	< 0.005	< 0.005	806.12
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	< 0.005	218.28
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.90	5.04	164.80
EPS QOQ	0.64	7.36	1050.50
FCF QOQ	0.25	-0.70	185.27
Revenue QOQ	-0.03	0.15	390.88
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	181.75	277.13	52.48
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.82	0.81	-1.99
Quick Ratio	7.94	4.99	-37.11
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	27.06	26.60	-1.70
Cash	98.09	86.34	-11.98
Capex	-0.14	-0.13	9.26
Free Cash Flow	11.62	3.47	-70.11
Revenue	3.23	3.73	15.35
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	7.94	4.64	-41.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	337.39	-88.55	-73.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating